Potential usefulness of basic fibroblast growth factor as a treatment for stroke

Cerebrovascular Diseases

Volumn 9, Issue 3, 1999, Pages 131-135

  Ay, Hakan ^a   Ay, Ilknur ^a   Koroshetz, Walter J ^a   Finklestein, Seth P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Basic fibroblast growth factor; Cerebral ischemia; Ischemic stroke; Neuroprotection; Recovery

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR;

BRAIN ISCHEMIA; CAT; CELL PROTECTION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERANCE; GERBIL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MOUSE; NEUROPROTECTION; NONHUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAT; REVIEW; SENSORIMOTOR FUNCTION; SYNAPSE;

ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; CEREBROVASCULAR DISORDERS; FIBROBLAST GROWTH FACTOR 2; MOLECULAR WEIGHT; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS;

EID: 0032892598     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000015941     Document Type: Review

References (41)

1. Cuevas P, Gimenez-Gallego G, Martinez-Murillo R, Carceller F: Immunohistochemical localization of basic fibroblast growth factor in ependymal cells of the rat lateral and third ventricles. Acta Anat 1991;141:307-310.
2. Matsuyama A, Iwata H, Okumura N, Yoshida S, Imaizumi K, Lee Y, Shiraishi S, Shiosaka S: Localization of basic fibroblast growth factor-like immunoreactivity in the rat brain. Brain Res 1992;587:49-65.
3. Gonzalez AM, Berry M, Maher PA, Logan A, Baird A: A comprehensive analysis of the distribution of FGF-2 and FGFR 1 in the rat brain. Brain Res 1995;701:201-226.
4. Wanaka A, Johnson EM Jr, Milbrandt J: Localization of FGF receptor mRNA in the adult rat central nervous system by in situ hybridization. Neuron 1990;5:267-281.
5. Mattson MP, Barger SW: Programmed cell life: Neuroprotective signal transduction and ischemic brain injury; in Moskowitz MA and Caplan LR (eds): Cerebrovascular Diseases. 19th Princeton Stroke Conf. Newton, Butterworth-Heinemann 1995, pp 271-290.
6. Finklestein SP, Fanning PJ, Caday CG, Powell PP, Foster J, Clifford EM, Klagsbrun M: Increased levels of basic fibroblast growth factor (bFGF) following focal brain injury. Restorative Neurol Neurosci 1990;1:387-394.
7. Speliotes EK, Caday CG, Do T, Weise J, Kowall NW, Finklestein SP: Increased expression of basic fibroblast growth factor (bFGF) following focal cerebral infarction in the rat. Brain Res Mol Brain Res 1996;39:31-42.
8. Logan A, Frautschy SA, Gonzalez A-M, Baird A: A time course for the focal elevation of synthesis of basic fibroblast growth factor and one of it high-affinity receptors (flg) following a localized cortical brain injury. J Neurosci 1992; 12:3828-3837.
9. Masumura M, Murayama N, Inoue T, Ohno T: Selective induction of fibroblast growth factor receptor-1 mRNA after transient focal ischemia in the cerebral cortex of rats. Neurosci Lett 1996;213:119-122.
10. Fisher M, Meadows M-E, Do T, Weise J, Trubetskoy V, Charette M, Finklestein SP: Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1995;15:953-959.
11. Cuevas P, Fernandes-Ayerdi A, Carceller F, Colin S, Mascarelli F, Muñoz-Willery I, Gimenez-Gallego G: Central nervous system distribution of fibroblast growth factor injected into the blood stream. Neurol Res 1996;18: 267-272.
12. Yamada K, Kinoshita A, Kohmura E, Sakaguchi T, Taguchi J, Kataoka K, Hayakawa T: Basic fibroblast growth factor prevents thalamic degeneration after cortical infarction. J Cereb Blood Flow Metab 1991;11:472-478.
13. Nakata N, Kato H, Kogure K: Protective effects of basic fibroblast growth factor against hippocampal neuronal damage following cerebral ischemia in the gerbil. Brain Res 1993;605: 354-356.
14. Nozaki K, Finklestein SP, Beal MF: Basic fibroblast growth factor protects against hypoxia-ischemia and NMDA neurotoxicity in neonatal rats. J Cereb Blood Flow Metab 1993;13: 221-228.
15. Koketsu N, Berlove DJ, Moskowitz MA, Kowall NW, Caday CG, Finklestein SP: Pretreatment with intraventricular basic fibroblast growth factor (bFGF) decreases infarct size following focal cerebral ischemia in rats. Ann Neurol 1994;35:451-457.
16. Tanaka R, Miyasaka Y, Yada K, Ohwada T, Kameya T: Basic fibroblast growth factor increases regional cerebral blood flow and reduces infarct size after experimental ischemia in a rat model. Stroke 1995;26:2154-2158.
17. Huang Z, Chen K, Huang PL, Finklestein SP, Moskowitz MA: bFGF ameliorates focal ischemic injury by blood flow-independent mechanisms in eNOS mutant mice. Am J Physiol 1996;272:H1401-H1405.
18. Jiang N, Finklestein SP, Do T, Caday CG, Charette M, Choop M: Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the rat. J Neurol Sci 1996;139:173-179.
19. Tatlisumak T, Takano K, Carano RA, Fisher M: Effect of basic fibroblast growth factor on experimental focal ischemia studied by diffusion-weighted and perfusion imaging. Stroke 1996;27:2292-2297.
20. Bethel A, Kirsch JR, Koehler RC, Finklestein SP: Intravenous basic fibroblast growth factor decreases brain injury resulting from focal ischemia in cats. Stroke 1997;28:609-615.
21. Ren JM, Finklestein SP: Time window of infarct reduction by intravenous basic fibroblast growth factor in focal cerebral ischemia. Eur J Pharmacol 1997;327:11-16.
22. Cuevas P, Carceller F, Ortega S, Zazo M, Nieto I, Gimenez-Gallego G: Hypotensive activity of fibroblast growth factor. Science 1991;254: 1208-1210.
23. Rosenblatt S, Irikura K, Caday CG, Finklestein SP, Moskowitz MA: Basic fibroblast growth factor (bFGF) dilates rat pial arterioles. J Cereb Blood Flow Metab 1994;14:70-74.
24. Jones TA, Schauert T: Use-dependent growth of pyramidal neurons after neocortical damage. J Neurosci 1994;14:2140-2152.
25. Stroemer RP, Kent TA, Hulsebosch CE: Neocortical neural sprouting, synaptogenesis, and behavioral recovery after neocortical infarction in rats. Stroke 1995;26:2135-2144.
26. Weiller C, Chollet F, Friston KJ, Wise RJ, Frackowiak RS: Functional reorganization of the brain in recovery from striatocapsular infarction in man. Ann Neurol 1992;31:463-472.
27. Cao Y, D'Olhaberriague L, Vikingstad EM, Levine SR, Welch KM: Pilot study of functional MRI to assess cerebral activation of motor function after poststroke hemiparesis. Stroke 1998;29:112-122.
28. Cramer SC, Nelles G, Benson RR, Kaplan JD, Parker RA, Kwong KK, Kennedy DN, Finklestein SP, Rosen BR: A functional MRI study of subjects recovered from hemiparetic stroke. Stroke 1997;28:2518-2527.
29. Rowntree S, Kolb B: Blockade of basic fibroblast growth factor retards recovery from motor cortex injury in rats. Eur J Neurosci 1997;9: 2432-2441.
30. Patel MN, McNamara JO: Selective enhancement of axonal branching of cultured dentate gyrus neurons by neurotrophic factors. Neuroscience 1995;69:763-770.
31. Walicke P, Cowan WM, Ueno N, Baird A, Guillemin R: Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. Proc Natl Acad Sci USA 1986;83:3012-3016.
32. Himmelseher S, Pfenninger E, Georgieff M: Effects of basic fibroblast growth factor on hippocampal neurons after axonal injury. J Trauma 1997;42:659-664.
33. Otto D, Unsicker K: Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J Neurosci 1990;10:1912-1921.
34. Kawamata T, Alexis NE, Dietrich WD, Finklestein SP: Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat. J Cereb Blood Flow Metab 1996;16:542-547.
35. Kawamata T, Dietrich DW, Schallert T, Gotts JE, Cocke RR, Benowitz LI, Finklestein SP: Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proc Natl Acad Sci USA 1997;94:8179-8184.
36. Mazue G, Bertolero F, Jacob C, Sarmientos P, Roncucci R: Preclinical and clinical studies with recombinant human basic fibroblast growth factor. Ann NY Acad Sci 1991;638: 329-340.
37. Mazue G, Bertolero F, Garofano L, Brughera M, Carminati P: Experience with the preclinical assessment of basic fibroblast growth factor (bFGF). Toxicol Lett 1992;64-65:329-338.
38. Mazue G, Newman AJ, Scampini G, Della Torre P, Hard GC, Iatropoulos MJ, Williams GM, Bagnasco SM: The histopathology of kidney changes in rats and monkeys following intravenous administration of massive doses of FCE 26184, human basic fibroblast growth factor. Toxicol Pathol 1993;21:490-501.
39. Gross JL, Herblin WF, Dusak BA, Czerniak P, Diamond MD, Sun T, Eidsvoog K, Dexter DL, Yayon A: Effects of modulation of basic fibroblast growth factor on tumor growth in vivo. J Natl Cancer Inst 1993;85:121-131.
40. Leith JT, Michelson S: Effects of administration of basic fibroblast growth factor on hypoxic fractions in xenografted DLD-2 human tumors: Time dependence. Br J Cancer 1993;68: 727-731.
41. ®) in acute stroke (abstract). 23rd Int Joint Conf Stroke Cereb Circ, Stroke 1998;29;287.